US 8563039
Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions
granted A61KA61K31/715A61K31/728
Quick answer
US patent 8563039 (Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions) held by Anika Therapeutics S.r.l. expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Anika Therapeutics S.r.l.
- Grant date
- Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/715, A61K31/728, A61K31/737, A61K31/795